Liu Ying, Snedecor Elizabeth R, Zhang Xu, Xu Yanfeng, Huang Lan, Jones Evan C, Zhang Lianfeng, Clark Richard A, Roop Dennis R, Qin Chuan, Chen Jiang
Institute of Laboratory Animal Science, Chinese Academy of Medical Science and Comparative Medical Center, Peking Union Medical College; Key Laboratory of Human Disease Comparative Medicine, Ministry of Health, Beijing, China.
Department of Pathology, Stony Brook University, Stony Brook, New York, USA; Graduate Program in Genetics, Stony Brook University, Stony Brook, New York, USA.
J Invest Dermatol. 2016 Jan;136(1):45-51. doi: 10.1038/JID.2015.375.
Dominant mutations in keratin genes can cause a number of inheritable skin disorders characterized by intraepidermal blistering, epidermal hyperkeratosis, or abnormalities in skin appendages, such as nail plate dystrophy and structural defects in hair. Allele-specific silencing of mutant keratins through RNA interference is a promising therapeutic approach for suppressing the expression of mutant keratins and related phenotypes in the epidermis. However, its effectiveness on skin appendages remains to be confirmed in vivo. In this study, we developed allele-specific small interfering RNAs capable of selectively suppressing the expression of a mutant Krt75, which causes hair shaft structural defects characterized by the development of blebs along the hair shaft in mice. Hair regenerated from epidermal keratinocyte progenitor cells isolated from mutant Krt75 mouse models reproduced the blebbing phenotype when grafted in vivo. In contrast, mutant cells manipulated with a lentiviral vector expressing mutant Krt75-specific short hairpin RNA (shRNA) persistently suppressed this phenotype. The phenotypic correction was associated with a significant reduction of mutant Krt75 mRNA in the skin grafts. Thus, data obtained from this study demonstrated the feasibility of utilizing RNA interference to achieve durable correction of hair structural phenotypes through allele-specific silencing of mutant keratin genes.
角蛋白基因的显性突变可导致多种遗传性皮肤病,其特征为表皮内水疱形成、表皮角化过度或皮肤附属器异常,如甲板营养不良和毛发结构缺陷。通过RNA干扰实现突变角蛋白的等位基因特异性沉默是一种很有前景的治疗方法,可用于抑制表皮中突变角蛋白的表达及相关表型。然而,其对皮肤附属器的有效性仍有待在体内得到证实。在本研究中,我们开发了等位基因特异性小干扰RNA,能够选择性抑制突变型Krt75的表达,该突变型Krt75会导致小鼠毛干出现沿毛干形成小泡的结构缺陷。从突变型Krt75小鼠模型分离的表皮角质形成细胞祖细胞再生的毛发在体内移植时会重现小泡表型。相反,用表达突变型Krt75特异性短发夹RNA(shRNA)的慢病毒载体处理的突变细胞持续抑制了这种表型。表型纠正与皮肤移植物中突变型Krt75 mRNA的显著减少有关。因此,本研究获得的数据证明了利用RNA干扰通过突变角蛋白基因的等位基因特异性沉默实现毛发结构表型持久纠正的可行性。